CD4 and systemic lupus erythematosus: In line with these studies, our data suggest that the ratio of peripheral CD8+ to CD4+ T cells and RORγt+CD8+ T cells increased in lupus-prone (Figure 3) and pristane-treated (Supplementary Figure S3) mice.